Mark Davies
Dr Victoria Gamerman
Dr Ramesh Dursuvala
As the Information Officer for Research, Ramesh Durvasula is responsible for all of the IT and informatics capabilities that support the drug discovery efforts of Lilly Research Labs.
Dr. Durvasula has focused his career on the intersection of life science and informatics. For more than a decade, he built award-winning technology platforms for Bristol-Myers-Squibb (BMS) research labs. Most recently, Ramesh was Executive Director of Discovery IT and Automation at BMS. He has held a variety of leadership roles during his 12-year tenure at BMS. He successfully led his team through delivery of various IT strategies and roadmaps for biologics, laboratory modernization, translational R&D, in-vivo excellence, high-throughput workflows and leveraging data for quantitative decision making. He is an active leader in many industry forums, such as the Pistoia Alliance and the Allotrope Foundation. Prior to BMS, he spent several years at Tripos, a computational chemistry software firm. Ramesh earned his BA in Chemistry and PhD in Biochemistry & Molecular Genetics from the University of Virginia.
Dr Kelly Zou
Kelly Zou, Ph.D., PStat® is Vice President, Medical Analytics & Insights, R&D and Medical, Upjohn Division, Pfizer Inc. She is an elected Fellow of the American Statistical Association and an Accredited Professional Statistician. Previously, she was Senior Director, Global Real World Evidence Center of Excellence and Senior Director, Statistical Center for Outcomes, Real World & Aggregate Data at Pfizer. She was Associate Professor of Radiology at Harvard Medical School, as well as Director of Biostatistics at its affiliated teaching hospitals. She was Associate Director of Rates at Barclays Capital. She received both MA and PhD degrees in Statistics from the University of Rochester, following a BA in Mathematics (Summa Cum Laude), with a Minor in Physics. She completed her Postdoctoral Fellowship at Harvard. Her research interests include healthcare policy, big data, and outcomes research, with over 140 professional articles and 4 books. She has played several leadership roles: Chair, Committee of Presidents of Statistical Societies Awards; Chair, Statistical Partnerships among Academe, Industry, and Government Committee, American Statistical Association (ASA); Chair, ASA Health Care Policy Statistics Section; Vice Chair, ASA Committee on Applied Statisticians; Member, Board of Directors and Publications Committee, International Chinese Statistical Association. She was featured as an Outstanding Woman in Data Analytics by Forbes, an Inspirational Women in Statistics & Data Science by Wiley and the Royal Statistical Society, and an Accomplished Woman in Statistics and Data Science by the ASA.
Dr David Fenstermacher
Dr. David Fenstermacher is currently the Vice President R&D-Bioinformatics at Medimmune, LLC. With more than 30 years of research experience as a molecular biologist and bioinformaticist, he has held several academic appointments at multiple universities and led several national and international informatics projects.
During his twenty years in bioinformatics, David designed and directed the implementation of numerous bioinformatics and biomedical informatics distributed computing systems to support basic, translational and clinical research, including multiple institution research projects. He has also designed data warehouses that integrate patient-level clinical data, genomics (genome-wide association studies, massively parallel sequencing, array-based technologies) and other ‘omics data to support studies focused on cancer and other human diseases. Most recent research is focused on developing a federated semantic approach for data integration to support target identification/validation and precision medicine.
David received his PhD in Molecular Biology and Genetics from the University of North Carolina at Chapel Hill.
Dr Anthony Philippakis M.D., Ph.D.
Anthony Philippakis is the Chief Data Officer of the Broad Institute of MIT and Harvard, where he is also an institute scientist.
Philippakis is committed to bridging the gap between data sciences and medicine. He is a cardiologist at Brigham and Women’s Hospital, where his primary focus is caring for patients with rare genetic cardiovascular diseases. At the Broad Institute he directs the Data Sciences Platform, an organization of over 100 software engineers and computational biologists that develops software for analyzing genomic and clinical data. In addition to his roles at the Broad Institute and Brigham and Women’s Hospital, Philippakis is a Venture Partner at GV, focusing on machine learning, distributed computing, and genomics.
Philippakis received his M.D. from Harvard Medical School and completed a Ph.D. in biophysics at Harvard. As an undergraduate, he studied mathematics at Yale University, and later completed the Part III (equivalent to M.Phil) in mathematics at Cambridge University.
Andy Nelson
Andy works in Illumina’s Product Development organization on cloud operations & architecture for the BaseSpace suite of Informatics SaaS platforms.
These providing data management and analysis capabilities for full genome DNA sequencing, and during 2018 consumed over 4 Million compute hours, processing over 10PB of genomic data… equivalent to the entire Netflix video library every quarter.
Prior to working at Illumina, Andy was a cross-industry technical consultant, and brings over 2 decade’s experience in designing and managing high volume data storage and distributed compute systems across a diverse range of industries including telecommunications, insurance, banking, pharmaceutical and biotechnology.
Thomas Alisi
Software engineer with entrepreneurial attitude, problem solving approach and a particular propensity for large scale cloud computing projects.
I can lead and implement the deployment of software architectures for data driven digital products and award winning digital campaigns for international brands and agencies.
With my scientific background, I have published for international conferences and journals and I have been awarded numerous research grants.
I am also the proud founder and manager of an invitation only community of ~200 London-based technical leads and developers.